Any retatrutide being offered outside of a regulated clinical trial in the UK is unlicensed, and its quality, safety, and efficacy cannot be guaranteed
While the study has limitations (retrospective, self-selected population, company-authored), having published peer-reviewed data is uncommon in this market
PMID: 26236730 Secondary BPC-157: eNOS / VEGFR2 NO System & VEGF-Mediated Angiogenesis BPC-157 (10mg) modulates the nitric oxide system through both eNOS and iNOS pathways, and upregulates VEGFR2 expression in endothelial cell models, supporting pro-angiogenic signaling cascades
Use abdomen one week, thighs the next, upper arms after that, then back to abdomen
Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 10 Feb
Reduces inflammation and oxidative stress Boosts energy, mental clarity, and focus Boost Your IV Therapy With Injections and Add-Ons Dr